Prime medicine to participate in upcoming investor conferences

Cambridge, mass., aug. 26, 2025 (globe newswire) -- prime medicine, inc. (nasdaq: prme), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that company management will participate in the following upcoming conferences: citi's 2025 biopharma back to school conference: fireside chat on tuesday, september 2, 2025, at 4:45 p.m.
PRME Ratings Summary
PRME Quant Ranking